Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 1329 of 1329 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/19/23
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 08/30/21
End: 07/31/28
Due: 07/31/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia | NCT05703178 | Northwestern University | user2@example.com | None | 2023-01-19 | 2026-11-30 | 2027-11-30 | - | - | 2025-07-14 |
| Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | NCT00727532 | Northwestern University | user2@example.com | None | 2008-07-31 | 2013-09-30 | 2014-09-30 | - | - | 2025-07-14 |
| Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission | NCT02530125 | Northwestern University | user2@example.com | None | 2015-09-30 | 2017-01-31 | 2018-01-31 | - | - | 2025-07-14 |
| Study in Parkinson Disease of Exercise | NCT04284436 | Northwestern University | user2@example.com | None | 2021-08-30 | 2028-07-31 | 2029-07-31 | - | - | 2025-07-14 |